ID19474A - Turunan tiazola - Google Patents
Turunan tiazolaInfo
- Publication number
- ID19474A ID19474A IDP972653A ID972653A ID19474A ID 19474 A ID19474 A ID 19474A ID P972653 A IDP972653 A ID P972653A ID 972653 A ID972653 A ID 972653A ID 19474 A ID19474 A ID 19474A
- Authority
- ID
- Indonesia
- Prior art keywords
- tiazola
- tiazola down
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20089896 | 1996-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID19474A true ID19474A (id) | 1998-07-16 |
Family
ID=16432095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDP972653A ID19474A (id) | 1996-07-31 | 1997-07-31 | Turunan tiazola |
Country Status (17)
Country | Link |
---|---|
US (1) | US6140330A (fr) |
EP (1) | EP0858452B1 (fr) |
KR (1) | KR19990063910A (fr) |
CN (1) | CN1070856C (fr) |
AR (1) | AR008111A1 (fr) |
AT (1) | ATE214381T1 (fr) |
AU (1) | AU695817B2 (fr) |
BR (1) | BR9706792A (fr) |
CA (1) | CA2233611A1 (fr) |
DE (1) | DE69711020T2 (fr) |
DK (1) | DK0858452T3 (fr) |
ES (1) | ES2179355T3 (fr) |
HK (1) | HK1016586A1 (fr) |
ID (1) | ID19474A (fr) |
PT (1) | PT858452E (fr) |
TW (1) | TW513418B (fr) |
WO (1) | WO1998004536A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849769A (en) * | 1994-08-24 | 1998-12-15 | Medivir Ab | N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection |
KR20010082501A (ko) | 1997-10-27 | 2001-08-30 | 개리 이. 프라이드만 | 4-아미노티아졸 유도체, 그 제조방법 및 싸이클린-의존성키나아제의 억제제로서의 이용방법 |
CA2309319A1 (fr) | 1997-11-10 | 1999-05-20 | Bristol-Myers Squibb Company | Composes de benzothiazole utilises comme inhibiteurs de la proteine tyrosine-kinase |
EP1077960A1 (fr) * | 1998-05-12 | 2001-02-28 | American Home Products Corporation | Derives de l'acide (2-acylaminothiazole-4-yl)acetique |
ATE288904T1 (de) * | 1998-06-18 | 2005-02-15 | Bristol Myers Squibb Co | Durch kohlenstoff substituierte aminothiazole als inhibitoren von zyclin-abhägigen kinasen |
US6407124B1 (en) | 1998-06-18 | 2002-06-18 | Bristol-Myers Squibb Company | Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
GB9823871D0 (en) * | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
US6114365A (en) * | 1999-08-12 | 2000-09-05 | Pharmacia & Upjohn S.P.A. | Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
TWI284639B (en) * | 2000-01-24 | 2007-08-01 | Shionogi & Co | A compound having thrombopoietin receptor agonistic effect |
WO2001056567A1 (fr) * | 2000-02-04 | 2001-08-09 | Novo Nordisk A/S | Derives de 2,4-diaminothiazole |
PL357099A1 (en) | 2000-02-07 | 2004-07-12 | Abbott Gmbh & Co.Kg | 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
CA2446939C (fr) * | 2001-05-16 | 2005-08-02 | Matthias Stein-Gerlach | Derives de pyridylpyrimidine utilises comme composes actifs contre des infections et des maladies a prions |
HN2002000156A (es) | 2001-07-06 | 2003-11-27 | Inc Agouron Pharmaceuticals | Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización. |
EP1724270A3 (fr) | 2001-07-19 | 2007-01-03 | Pfizer Italia S.r.l. | Dérivés de phenylacetamido-thiazole, leur procédé de préparation et leur utilisation en tant qu'agents antitumoraux |
CN1638777A (zh) * | 2002-01-25 | 2005-07-13 | 法玛西雅公司 | 用于预防或治疗炎症相关病症的醛固酮阻滞剂治疗 |
US7101898B2 (en) * | 2002-02-01 | 2006-09-05 | Novo Nordisk A/S | Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
ES2599529T3 (es) * | 2003-08-12 | 2017-02-02 | Shionogi & Co., Ltd. | Compuestos que tienen agonismo hacia el receptor de trombopoyetina |
US7910613B2 (en) * | 2004-09-22 | 2011-03-22 | H. Lundbeck A/S | 2-acylaminothiazole derivatives |
US7674912B2 (en) * | 2005-04-25 | 2010-03-09 | H. Lundbeck A/S | Pro-drugs of N-thiazol-2-yl-benzamide derivatives |
EP2069355A4 (fr) * | 2006-07-19 | 2010-03-24 | Astrazeneca Ab | Nouveaux composés spiropipéridine tricycliques, leur synthèse et leur usage comme modulateurs de l'activité du récepteur chemokine |
WO2009011654A1 (fr) * | 2007-07-17 | 2009-01-22 | Astrazeneca Ab | Procédé de préparation de spiropipéridines cycliques |
WO2009120826A1 (fr) * | 2008-03-27 | 2009-10-01 | Wyeth | Composés de 2-aryl- et de 2-hétéroaryl-thiazolyle, leurs procédés de préparation et d'utilisation |
CN102482283A (zh) * | 2009-08-28 | 2012-05-30 | 阵列生物制药公司 | Raf抑制剂化合物及其使用方法 |
PT2588475E (pt) * | 2010-07-02 | 2015-09-08 | Gilead Sciences Inc | Inibidores de cinase reguladora dos sinais da apoptose |
WO2012104857A1 (fr) * | 2011-02-04 | 2012-08-09 | Council Of Scientific & Industrial Research | Amidobenzothiazoles et procédé de préparation de ceux-ci |
ES2489297B1 (es) * | 2013-01-22 | 2015-06-10 | Consejo Superior De Investigaciones Científicas (Csic) | Benzotiazoles sustituidos y sus aplicaciones terapeuticas para el tratamiento de enfermedades humanas |
GB201401886D0 (en) | 2014-02-04 | 2014-03-19 | Lytix Biopharma As | Neurodegenerative therapies |
CN110317230B (zh) * | 2018-03-30 | 2023-11-07 | 上海昇悦医药科技有限公司 | 磷酸盐类衍生物及其用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0063564A1 (fr) * | 1980-11-04 | 1982-11-03 | ANDERSON, Martin C. | Ensemble d'elements en couleurs fondamentales permettant d'obtenir des palettes aux tons assortis |
US4957932A (en) * | 1987-11-25 | 1990-09-18 | Merck Frosst Canada, Inc. | Benzoheterazoles |
IL90337A0 (en) * | 1988-05-24 | 1989-12-15 | Pfizer | Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents |
JP2869561B2 (ja) * | 1989-05-22 | 1999-03-10 | 大塚製薬株式会社 | 血小板粘着抑制剤 |
TW205041B (fr) * | 1989-08-07 | 1993-05-01 | Fujisawa Pharmaceutical Co | |
WO1993021168A1 (fr) * | 1992-04-10 | 1993-10-28 | Merck Frosst Canada Inc. | Alcools benzyliques a substitution thiazole utilises comme antagonistes de leucotrienes |
WO1993021169A1 (fr) * | 1992-04-10 | 1993-10-28 | Merck Frosst Canada Inc. | Alcools benzyliques substitues par benzothiazole, utilises comme antagonistes de leucotrienes |
KR0134069B1 (ko) * | 1993-02-19 | 1998-04-22 | 유미꾸라 레이이찌 | 벤조티아졸 술폰아미드 유도체, 그의 제조법 및 그의 용도 |
-
1997
- 1997-07-28 TW TW086110703A patent/TW513418B/zh not_active IP Right Cessation
- 1997-07-29 CA CA002233611A patent/CA2233611A1/fr not_active Abandoned
- 1997-07-29 BR BR9706792-0A patent/BR9706792A/pt not_active Application Discontinuation
- 1997-07-29 EP EP97933046A patent/EP0858452B1/fr not_active Expired - Lifetime
- 1997-07-29 CN CN97190997A patent/CN1070856C/zh not_active Expired - Fee Related
- 1997-07-29 ES ES97933046T patent/ES2179355T3/es not_active Expired - Lifetime
- 1997-07-29 DK DK97933046T patent/DK0858452T3/da active
- 1997-07-29 DE DE69711020T patent/DE69711020T2/de not_active Expired - Fee Related
- 1997-07-29 AU AU36354/97A patent/AU695817B2/en not_active Ceased
- 1997-07-29 KR KR1019980702383A patent/KR19990063910A/ko not_active Application Discontinuation
- 1997-07-29 AT AT97933046T patent/ATE214381T1/de not_active IP Right Cessation
- 1997-07-29 PT PT97933046T patent/PT858452E/pt unknown
- 1997-07-29 WO PCT/JP1997/002609 patent/WO1998004536A1/fr not_active Application Discontinuation
- 1997-07-29 US US09/043,642 patent/US6140330A/en not_active Expired - Fee Related
- 1997-07-30 AR ARP970103439A patent/AR008111A1/es not_active Application Discontinuation
- 1997-07-31 ID IDP972653A patent/ID19474A/id unknown
-
1999
- 1999-04-12 HK HK99101470A patent/HK1016586A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0858452A1 (fr) | 1998-08-19 |
WO1998004536A1 (fr) | 1998-02-05 |
CA2233611A1 (fr) | 1998-02-05 |
CN1070856C (zh) | 2001-09-12 |
DE69711020T2 (de) | 2002-11-21 |
KR19990063910A (ko) | 1999-07-26 |
ES2179355T3 (es) | 2003-01-16 |
BR9706792A (pt) | 2001-11-27 |
AR008111A1 (es) | 1999-12-09 |
HK1016586A1 (en) | 1999-11-05 |
AU695817B2 (en) | 1998-08-20 |
EP0858452B1 (fr) | 2002-03-13 |
TW513418B (en) | 2002-12-11 |
DE69711020D1 (de) | 2002-04-18 |
AU3635497A (en) | 1998-02-20 |
ATE214381T1 (de) | 2002-03-15 |
DK0858452T3 (da) | 2002-05-21 |
PT858452E (pt) | 2002-07-31 |
CN1198160A (zh) | 1998-11-04 |
US6140330A (en) | 2000-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9703884A (pt) | Cicloalcanopiridinas | |
ATE208395T1 (de) | Thiophenopyrimidine | |
BR9704464A (pt) | Evisceradora | |
ID19474A (id) | Turunan tiazola | |
ATE262512T1 (de) | Arylalkanoylpyridazine | |
ATE208773T1 (de) | Chinoxalindione | |
ID18095A (id) | Turunan tetrahidrokinolin | |
DE59609702D1 (de) | Pulversprüheinrichtung | |
ATE353652T1 (de) | Östroprogestatives antikonzeptionsmittel | |
BR9703563A (pt) | Hidromancal | |
BR9703835A (pt) | Hidromancal | |
BR9707467A (pt) | 1-Pirazol-3-iletil-4-indol-3-ilpiperdinas | |
DE59710376D1 (de) | Phosphatidyloligoglycerine | |
BR9708716A (pt) | 3-cianoaril-pirazóis | |
ATE267568T1 (de) | Epithese | |
BR7601548U (pt) | Tomadamax | |
BR9604349A (pt) | Xapisqueira | |
BR7603126U (pt) | Bate - estacas | |
BR7603088U (pt) | Kitgeométrico | |
BR7602320U (pt) | Supedânea | |
BR7601926U (pt) | Sofá-mesa | |
BR7601720U (pt) | Paraglayder | |
BR7603380U (pt) | Abratporta | |
BR7601509U (pt) | Gafa | |
BR7601508U (pt) | Cogafa |